April 2 (Reuters) - Resonance Health Ltd (RHT) :
- TRIALSWEST IS EXPECTED TO CONTRIBUTE A$2 MILLION IN REVENUE AND A$0.67 MILLION IN EBITDA ON ANNUALISED BASIS
- ACQUISITION OF TRIALSWEST GROUP
- CONTRACTED TO ACQUIRE 100% OF TRIALSWEST PTY LTD
- WILL PAY UPFRONT CASH CONSIDERATION OF A$4 MILLION UNDER TERMS OF SHARE SALE AGREEMENT
- FURTHER A$4 MILLION MAY BE PAYABLE TO TRIALSWEST VENDORS UNDER EARNOUT ARRANGEMENT SUBJECT TO CONDITIONS
(([email protected];))
